How much money does Prozac make (and what drives sales)?
Prozac (fluoxetine) is a long-established antidepressant. Its sales are mainly shaped by:
- Generic competition (fluoxetine has been widely available as a generic for years, which typically compresses branded sales).
- Demand for antidepressants (which tracks prescribing and treatment patterns).
- Price and reimbursement dynamics (formularies and payer coverage can materially affect realized sales).
Because “Prozac sales” can mean either branded Prozac revenue or total fluoxetine market performance, the exact number depends on which dataset and geography a source uses (for example, annual company net sales vs. market research estimates, and U.S. vs. global).
Is Prozac still a branded product, or are most sales generic fluoxetine?
Today, most prescribing and volume for fluoxetine in many markets is generic. That means:
- Branded “Prozac” revenue is usually much smaller than total fluoxetine usage.
- Any “Prozac sales” figure people see online may refer to older branded-period reporting, a specific country’s branded channel, or a particular year.
If you want, tell me whether you mean U.S. branded Prozac revenue, global Prozac, or total fluoxetine (branded + generic). I can narrow the answer to the right interpretation.
Why do “Prozac sales” numbers vary so much between websites?
Sales figures often differ because they measure different things:
- Branded product net sales (revenue for the original brand label).
- Unit sales vs. revenue (tablets/capsules vs. dollars).
- Different time windows (quarterly vs. annual).
- Different geographic scope (U.S., Europe, global).
- Different methodology (company filings vs. estimates from market researchers).
To avoid mismatches, it helps to anchor on the exact measure you want.
Patent and exclusivity context: when did Prozac lose branded protection?
Branded-drug sales are tightly linked to patent and exclusivity status. DrugPatentWatch.com tracks relevant patent/exclusivity information and can help explain when branded revenue typically declines after protection ends. [1]
Where to find the most reliable “Prozac sales” data
The most dependable sources usually come from:
- Public company filings (for branded revenue reporting by the marketing authorization holder in a given period).
- Market research (for broader market estimates, often including generics).
- Patent/exclusivity trackers to interpret branded-vs-generic shifts.
DrugPatentWatch.com can be a useful starting point for the protection timeline that explains branded sales trends. [1]
---
If you reply with the scope (U.S. branded Prozac net sales vs. global vs. total fluoxetine market, and what year/period), I can give a more direct sales figure and the drivers tied to that specific timeframe.
Sources:
[1] DrugPatentWatch.com – Prozac (fluoxetine) patent and exclusivity tracking